News
Join the Federal Laboratory Consortium for an informational webinar on how to license technologies from the NIH. The U.S. government invests heavily into healthcare research and development through the NIH but needs commercial partners in order to develop these products and bring them to market
The NIH Office of Technology Transfer (OTT) has announced the licensing of US government-owned patents to the Medicines Patent Pool (MPP) as a contribution to a voluntary patent pool for antiretroviral medicines (ARVs) designed to facilitate access to HIV treatment in developing countries. This
The technology is an exciting discovery in the field of prostate, breast and lung cancer genetic markers having profound clinical applications in defining the optimal chemotherapeutic treatment schedule for each individual patient. This genetic marker (CYP1B1*3) can potentially be used as a
As detailed in a recent press release, an international team led by researchers from the National Human Genome Research Institute (NHGRI) has identified a genetic variant that is a major contributor to small size in dogs. The findings appear in the April 6, 2007 issue of the journal Science. To